Mahendra Patel

Lincoln Pharma Increases Promoter Group Holding by 4.9% during FY 20-21 to 37.25%.

ICRA in its recent report has upgraded rating on long-term bank facilities to ICRA A and short-term facilities to ICRA A1 backed by steady growth in margins and improvement in risk profile

By SMEStreet Edit Desk

Apr 01, 2021 06:20 IST logo

2 Min read

Mr. Mahendra Patel, MD, Lincoln Pharmaceuticals Ltd

InFocus

Lincoln Pharmaceuticals Ltd Reports 16.70% Rise in Profit at Rs. 35.19 Crore

By SMEStreet Edit Desk

Nov 03, 2020 10:26 IST logo

3 Min read

News

Lincoln Pharmaceuticals Ltd To Manufacture Hydroxychloroquine and Hydroxychloroquine Sulfate Tablets to fight COVID19

By SMEStreet Desk

Apr 27, 2020 12:46 IST logo

2 Min read